- Lung cancer among younger, healthier, and non-smoking individuals "seems to be emerging as its own subtype of lung cancer — one for which new, powerful treatments are needed to make it a livable disease" said Dr. Geoffrey Oxnard, a lung cancer specialist at Dana-Farber Cancer Institute.
Tags: LungCancer, Genetics
- The Savage family moved to Boston from Ireland so that their daughter could be treated by Dana-Farber specialists for a rare form of brain cancer.
Tags: ChildhoodCancer, BrainTumors
- A study by Dr. Susan Dale Block found that the less money spent on medical care at the end of a person’s life resulted in a better death experience.
- Dana-Farber President and CEO Dr. Edward J. Benz, Jr., discussed the ongoing war on cancer and where the promising research is now
Tags: BasicResearch, Prevention
- In a recent national study led by Dr. Jane Weeks, 69 percent of those with stage 4 lung cancer and 81 percent of those with stage 4 colon cancer failed to understand that chemotherapy was not at all likely to cure their cancer.
Tags: chemotherapy, EndOfLife
- Dr. Erica Mayer, a medical oncologist at the Susan F. Smith Center for Women's Cancers at Dana-Farber, explained the concerns over soy consumption and its relationship to breast cancer.
- Nine factors explain some of the variance in the quality of life of patients with advanced cancer in end-of-life care, according to a study led by Dr. Holly Prigerson and associates at Dana-Farber and published in the Archives of Internal Medicine.
- Dr. Paul Richardson, clinical director for Dana-Farber's Jerome Lipper Center for Multiple Myeloma, shared the latest prognosis on treating and surviving this disease.
Showing 11-20 of 571 items